Endocrinology of bone mineralization: An update.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] 8. J Clin Densitom. 2026 Apr-Jun;29(2):101685. doi: 10.1016/j.jocd.2026.101685. Epub 2026 Feb 19. Personalized treatment pathways for adult osteomalacia. Slouma M(1), Bettaieb H(2), Rahmouni S(2), Cheour E(2), Lamloum M(2). Author information: (1)Pain center Rabta Hospital, Tunis, Tunisia; Faculty of Medicine of Tunis, University Tunis El Manar, Tunisia. Electronic address: maroua.slouma@gmail.com. (2)Pain center Rabta Hospital, Tunis, Tunisia; Faculty of Medicine of Tunis, University Tunis El Manar, Tunisia. Osteomalacia, characterized by impaired mineralization of the bone matrix in adults, arises from various causes, with vitamin D deficiency being the most prevalent. Additional etiologies include genetic disorders of vitamin D metabolism and excessive renal phosphate wasting. If left untreated, osteomalacia can result in bone pain, hypocalcemia, fractures, and skeletal deformities. This review provides an overview of current therapeutic strategies for osteomalacia, encompassing both pharmacological and non-pharmacological treatments, as well as a step-by-step management algorithm. We conducted a narrative review, synthesizing data from recent studies on osteomalacia. Key interventions discussed include vitamin D supplementation, phosphate therapy, biologics, surgical correction, and percutaneous tumor ablation. The management of osteomalacia involves a multimodal approach, tailored to the underlying cause. Treatment options span pharmacological therapies (vitamin D, calcium, phosphate, and biologics) to surgical and minimally invasive procedures, ensuring comprehensive care for affected patients. Copyright © 2026 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved. DOI: 10.1016/j.jocd.2026.101685